GoodRx Forecasts 2024 Revenue Of $800M-$810M Versus Consensus Of $857.80M, With Adjusted EBITDA Over $250M
GoodRx预测2024年收入为8亿至8.1亿美元,而市场预期为8.578亿美元,调整后的息税折旧摊销前利润超过2.5亿美元
GoodRx Forecasts 2024 Revenue Of $800M-$810M Versus Consensus Of $857.80M, With Adjusted EBITDA Over $250M
GoodRx预测2024年收入为8亿至8.1亿美元,而市场预期为8.578亿美元,调整后的息税折旧摊销前利润超过2.5亿美元
使用浏览器的分享功能,分享给你的好友吧